The aim of the Interdisciplinary Training in Cancer Research Program is to train young scientists to design and conduct research on significant problems in cancer by combining information and approaches from different scientific disciplines, including basic cellular and molecular biology, epidemiology, clinical trials and studies, and behavioral-social sciences. The rationale behind this program is to produce researchers who can excel in the increasingly complex environments and interdisciplinary approaches required for future cancer research. The program is a highly competitive and demanding training program. For 2-3 years, trainees work closely with two mentors who provide distinct, complementary areas of expertise; for example, by studying basic molecular and cellular mechanisms of neoplasia in combination with epidemiological analyses of related risk factors; or by participating in clinical research studies while studying behavioral or environmental factors that influence therapeutic outcomes. Our trainee projects transcend the traditional boundaries separating the molecular and cellular, clinical, epidemiologic and social cancer sciences. As a result, the program differs fundamentally in focus, goals and training plans from other pre- and postdoctoral training programs in the Seattle biomedical research community. The program supports two separate types of interdisciplinary trainees. The first are PhD candidates and postdoctoral fellows who work within two separate research groups to study a common problem in cancer using unique, and yet complementary research disciplines. The second are graduate students who are enrolled in a dual-degree program that allows PhD students in the Molecular and Cellular Biology (MCB) graduate program to earn a concurrent MS in Epidemiology. Trainees in either track are supported by this training grant as part of a broad initiative in Seattle to create a scientific culture in which interdisciplinary cancer research and training is encouraged and fostered. Three separate institutions ? University of Washington, Fred Hutchinson Cancer Research Center, and Seattle Children's Research Institute ? serve as primary research sites for trainees and their mentors. Faculty mentors have primary appointments at one of the three participating institutions, and the majority have additional cross- institutional affiliate appointments in the Fred Hutch/UW Cancer Consortium. We have created an environment across institutions where pre- and postdoctoral fellows can become conversant in the goals, assumptions, logic, methods, and vocabulary of multiple research disciplines.

Public Health Relevance

The Interdisciplinary Training in Cancer Research Program trains pre- and postdoctoral fellows in two or more distinct and historically separate cancer-related disciplines; specifically, the program supports trainees working on a research problem in cancer with two mentors whom provide collaborative supervision and direct, complementary approaches to studying cancer-related problems using tools and approaches from separate research disciplines. Over the past fifteen years, our program has provided support for 84 trainees (76 past and 8 current), including 26 past and present trainees over its most recent funded cycle (2014-19). The majority of our past trainees are still working in cancer-related research and/or patient care: 13% as academic faculty, 14% as staff scientists, 27% in biotechnology and industry, and the remainder as cancer physicians, research administrators or continuing training as pre- or postdoctoral fellows.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA080416-22
Application #
10017888
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Lim, Susan E
Project Start
1998-08-11
Project End
2024-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
22
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Washington
Department
Biochemistry
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Bender Ignacio, Rachel A; Madison, Amy T; Moshiri, Ata et al. (2018) A Population-based Study of Perinatal Infection Risk in Women with and without Systemic Lupus Erythematosus and their Infants. Paediatr Perinat Epidemiol 32:81-89
Ferreccio, Amy; Mathieu, Julie; Detraux, Damien et al. (2018) Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal. Cell Cycle 17:535-549
Gupta, Amitabha; Evans, Rena K; Koch, Lori B et al. (2018) Purification of kinetochores from the budding yeast Saccharomyces cerevisiae. Methods Cell Biol 144:349-370
Oseso, Linda N; Chiao, Elizabeth Y; Ignacio, Rachel A Bender (2018) Evaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines? J Natl Compr Canc Netw 16:927-932
Poudel, Kumud R; Roh-Johnson, Minna; Su, Allen et al. (2018) Competition between TIAM1 and Membranes Balances Endophilin A3 Activity in Cancer Metastasis. Dev Cell 45:738-752.e6
LlaurĂ³, Aida; Hayashi, Hanako; Bailey, Megan E et al. (2018) The kinetoplastid kinetochore protein KKT4 is an unconventional microtubule tip-coupling protein. J Cell Biol 217:3886-3900
Matreyek, Kenneth A; Starita, Lea M; Stephany, Jason J et al. (2018) Multiplex assessment of protein variant abundance by massively parallel sequencing. Nat Genet 50:874-882
Stewart, Mikaela D; Zelin, Elena; Dhall, Abhinav et al. (2018) BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes. Proc Natl Acad Sci U S A 115:1316-1321
Suzuki, Aussie; Gupta, Amitabha; Long, Sarah K et al. (2018) A Kinesin-5, Cin8, Recruits Protein Phosphatase 1 to Kinetochores and Regulates Chromosome Segregation. Curr Biol 28:2697-2704.e3
Munson, Paul; Liu, Yi; Bratt, Debra et al. (2018) Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection. Hum Vaccin Immunother 14:1820-1831

Showing the most recent 10 out of 177 publications